ORAMED PHARMORAMED PHARMORAMED PHARM

ORAMED PHARM

No trades
See on Supercharts
Market capitalization
‪358.36 M‬ILS
‪20.06 M‬ILS
‪4.87 M‬ILS
‪34.73 M‬
Beta (1Y)
1.74

About ORAMED PHARM

CEO
Nadav Kidron
Headquarters
New York
Website
Employees (FY)
15
Founded
2002
ISIN
US68403P2039
FIGI
BBG00H3P5B58
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ORMP is 860.0 ILA — it has decreased by 0.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange ORAMED PHARM stocks are traded under the ticker ORMP.
ORAMED PHARM is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
ORMP stock is 2.78% volatile and has beta coefficient of 1.74. Check out the list of the most volatile stocks — is ORAMED PHARM there?
One year price forecast for ORAMED PHARM has a max estimate of 16.0 ILA and a min estimate of 16.0 ILA.
ORMP earnings for the last quarter are −0.31 ILA whereas the estimation was −0.32 ILA which accounts for 5.88% surprise. Estimated earnings for the next quarter are −0.44 ILA. See more details about ORAMED PHARM earnings.
ORAMED PHARM revenue for the last quarter amounts to ‪2.60 M‬ ILA despite the estimated figure of ‪2.60 M‬ ILA. In the next quarter revenue is expected to reach ‪2.67 M‬ ILA.
Yes, you can track ORAMED PHARM financials in yearly and quarterly reports right on TradingView.
ORMP stock has fallen by 12.69% compared to the previous week, the month change is a 16.75% fall, over the last year ORAMED PHARM has showed a 4.19% increase.
ORMP net income for the last quarter is ‪48.42 M‬ ILS, while the quarter before that showed ‪−12.31 M‬ ILS of net income which accounts for 493.36% change. Track more ORAMED PHARM financial stats to get the full picture.
Today ORAMED PHARM has the market capitalization of ‪358.36 M‬, it has decreased by 1.53% over the last week.
No, ORMP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ORMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORAMED PHARM stock right from TradingView charts — choose your broker and connect to your account.
ORMP reached its all-time high on Nov 3, 2021 with the price of 9856.0 ILA, and its all-time low was 653.7 ILA and was reached on Jan 29, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 15.00 employees. See our rating of the largest employees — is ORAMED PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORAMED PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORAMED PHARM stock shows the sell signal. See more of ORAMED PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ORAMED PHARM future price: according to them, ORMP price has a max estimate of 1602.50 ILA and a min estimate of 1602.50 ILA. Read a more detailed ORAMED PHARM forecast: see what analysts think of ORAMED PHARM and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORAMED PHARM EBITDA is ‪−56.54 M‬ ILS, and current EBITDA margin is ‪−1.16 K‬%. See more stats in ORAMED PHARM financial statements.